Aehr Test Systems has faced significant challenges, including weak silicon carbide sales and intense competition, but remains a buy due to low valuation and potential EPS growth. Despite a sharp underperformance since early 2024 and a disappointing Q2, AEHR is diversifying revenue streams and expanding into AI processors, which could drive future growth. Key risks include ongoing supply chain issues, competition, and uncertainties in the silicon carbide market, but recent positive economic data from China offers hope for a turnaround.
Shares in semiconductor testing equipment company Aehr Test Systems (AEHR 4.81%) slumped by 8.6% in the week to Friday morning. The move came as the market digested the news of Chinese start-up DeepSeek's release of its updated artificial intelligence (AI) models.
Aehr Test Systems (AEHR -0.56%) is a provider of semiconductor testing equipment and other solutions and has exposure to growth trends, including artificial intelligence (AI) and EVs. Its products are highly regarded, and the company enjoys long-term growth catalysts.
Shares in Aehr Test Systems (AEHR -5.95%) declined by 25.7% in the week to Friday morning. The move comes after its second-quarter 2025 earnings report and management's commentary on its outlook for the year disappointed the market.
Aehr Test Systems' competitive advantage lies in its best-in-class test systems used for both EV and AI chips. The company's poor 2024 performance was due to an EV slowdown and reduced capex from its largest customer. Recent orders from AI and GaN customers signal strong growth for the second half of 2025 and increasing trust in Aehr's technology.
NEW YORK, NY / ACCESSWIRE / January 15, 2025 / If you suffered a loss on your Aehr Test Systems, Inc. (NASDAQ:AEHR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Shares of electric vehicle makers Tesla (TSLA 6.16%), Rivian (RIVN 3.97%), and Aehr Test Systems (AEHR 15.35%) rallied on Wednesday, up 5.2%, 4.7%, and 15.8%, respectively, as of 11:30 a.m. ET.
NEW YORK, NY / ACCESSWIRE / January 15, 2025 / If you suffered a loss on your Aehr Test Systems, Inc. (NASDAQ:AEHR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / January 15, 2025 / If you suffered a loss on your Aehr Test Systems, Inc. (NASDAQ:AEHR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
LOS ANGELES, CA / ACCESSWIRE / January 15, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Aehr Test Systems, Inc. ("Aehr" or "the Company") (NASDAQ:AEHR) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company 's securities between January 9, 2024 and March 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 3, 2025.
NEW YORK, NY / ACCESSWIRE / January 15, 2025 / If you suffered a loss on your Aehr Test Systems, Inc. (NASDAQ:AEHR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / January 15, 2025 / If you suffered a loss on your Aehr Test Systems, Inc. (NASDAQ:AEHR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.